Logotype for Uflex Limited

Uflex (500148) Q2 25/26 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Uflex Limited

Q2 25/26 earnings summary

14 Nov, 2025

Executive summary

  • H1 FY2026 sales grew 3.2% year-over-year, with EBITDA up 4% and PAT up 150% due to lower currency translation losses; Q2 FY26 faced operational headwinds from tariffs, GST transition, and a prolonged monsoon, but these are expected to ease.

  • Highest-ever volumes achieved in aseptic packaging units, up 5.5% year-over-year, with brownfield expansion at Sanand increasing capacity from 7 to 12 billion packs per annum.

  • Board approved unaudited standalone and consolidated financial results for Q2 and H1 FY26, and a new packaging films manufacturing line at Dharwad, Karnataka, with a proposed capacity of 54,000 MT per annum.

  • EPR rollout in India and global sustainability trends are driving demand for eco-friendly packaging, with strategic capex nearing completion.

Financial highlights

  • H1 FY2026 consolidated revenue grew 3.2% year-over-year to Rs. 77,828 million; Q2 FY26 revenue was flat year-over-year at Rs. 38,610 million, with consolidated net profit after tax for Q2 FY26 at ₹2,691 lacs, a turnaround from a loss in Q2 FY25.

  • Q2 FY26 normalized EBITDA was Rs. 3,895 million (down 12.4% YoY), with a margin of 10.1%; H1 FY26 normalized EBITDA was Rs. 8,593 million (down 5.9% YoY).

  • EBITDA guidance for FY2026 revised to INR 1,800-1,850 crore, down from earlier INR 2,000-2,100 crore.

  • Net debt as of Sep 2025: Rs. 77,533 million; net debt/normalized EBITDA: 4.51x.

  • Basic and diluted EPS (consolidated) for Q2 FY26 was ₹3.73, compared to a loss of ₹8.95 in Q2 FY25.

Outlook and guidance

  • FY2026 revenue growth guidance revised to 5%, with EBITDA expected at INR 1,800-1,850 crore; new capacities in Egypt, Mexico, and India expected to drive higher volumes and EBITDA in FY2027 and beyond.

  • Tariff issues are expected to be resolved soon, and GST rationalization is anticipated to boost consumption and industry growth.

  • Expansion projects at the Aseptic Packaging facility in Sanand, Gujarat, were successfully commissioned in October 2025.

  • 10% revenue growth possible in FY2027, depending on project commissioning.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more